{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:45:08Z","timestamp":1788867908738,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.03.080","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T16:41:11Z","timestamp":1273768871000},"page":"5109-5113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"28","author":[{"given":"Evangelia","family":"Farmaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kanakoudi-Tsakalidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trachana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Pratsidou-Gertsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tritsoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.03.080_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00008480-200312000-00007","article-title":"Novel therapies in pediatric rheumatic diseases","volume":"15","author":"Chira","year":"2003","journal-title":"Curr Opin Pediatr"},{"issue":"1 Suppl. 48","key":"10.1016\/j.vaccine.2010.03.080_bib2","first-page":"S67","article-title":"Infections and treatment of patients with rheumatic diseases","volume":"26","author":"Atzeni","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.03.080_bib3","first-page":"93","article-title":"High incidence of pneumonia in patients on anti-TNF therapy","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2010.03.080_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2010.03.080_bib5","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti-tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2010.03.080_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/iai.65.1.257-260.1997","article-title":"Role of tumour necrosis factor alpha in the pathogenesis of pneumococcal pneumonia in mice","volume":"65","author":"Takashima","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2010.03.080_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2008.07.007","article-title":"Vaccination and autoimmune rheumatic diseases","volume":"8","author":"Conti","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2010.03.080_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/rheumatology\/keh167","article-title":"Pneumococcal vaccination for RA patients on TNF-alpha antagonists","volume":"43","author":"Wright","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.vaccine.2010.03.080_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","article-title":"The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Elkayam","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.03.080_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.vaccine.2010.03.080_bib11","first-page":"952","article-title":"Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone","volume":"34","author":"Visvanathan","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.03.080_bib12","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2010.03.080_bib13","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.vaccine.2008.04.028","article-title":"Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23valent pneumococcal polysaccharide vaccine","volume":"26","author":"Gelinck","year":"2008","journal-title":"Vaccine"},{"issue":"RR-9","key":"10.1016\/j.vaccine.2010.03.080_bib14","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2010.03.080_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2010.03.080_bib16","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.vaccine.2005.06.002","article-title":"Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children","volume":"23","author":"Spoulou","year":"2005","journal-title":"Vaccine"},{"issue":"1 (Pt. 1)","key":"10.1016\/j.vaccine.2010.03.080_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1542\/peds.112.1.66","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection","volume":"112","author":"Nachman","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.080_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(07)70242-6","article-title":"The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease","volume":"8","author":"Bliss","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.080_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1542\/peds.2004-2312","article-title":"Safety and immunogenicity of the American Academy of Pediatrics\u2014recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients","volume":"116","author":"Ling Lin","year":"2005","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vaccine.2010.03.080_bib20","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.080_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2008.06.012","article-title":"Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)","volume":"14","author":"Pao","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.080_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00467-008-0989-5","article-title":"Evaluation of antibody response to the heptavalent pneumococcal conjugate vaccine in pediatric chronic kidney disease","volume":"24","author":"Vieira","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2010.03.080_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile idiopathic arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2010.03.080_bib24","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2010.03.080_bib25","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.080_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/14622416.5.4.417","article-title":"Variation in vaccine response in normal populations","volume":"5","author":"Ovsyannikova","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.vaccine.2010.03.080_bib27","series-title":"6th International Symposium on Pneumococci and Pneumococcal Diseases","article-title":"Streptococcus pneumoniae serotypes before and after introduction of pneumococcal conjugate vaccine in Greece (Abstract)","author":"Koutouzis","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.080_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijantimicag.2007.03.011","article-title":"Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology","volume":"30","author":"Poulakou","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2010.03.080_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/adc.87.1.18","article-title":"Should the new pneumococcal vaccine be used in high-risk children?","volume":"87","author":"Finn","year":"2002","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.vaccine.2010.03.080_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1586\/14760584.4.5.725","article-title":"Vaccination of the immunocompromised child","volume":"4","author":"Casswall","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.080_bib31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/587063","article-title":"Vaccination in patients with chronic rheumatic or autoimmune diseases","volume":"46","author":"Gl\u00fcck","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5 (September\u2013October)","key":"10.1016\/j.vaccine.2010.03.080_bib32","first-page":"589","article-title":"Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy","volume":"19","author":"Kanakoudi-Tsakalidou","year":"2001","journal-title":"Clin Exp Rheumatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10006237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:18:43Z","timestamp":1759400323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10006237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10006237"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}